Healthcare - Biotechnology - NYSE - CH
$ 2.39
-9.81 %
$ 231 M
Market Cap
-1.0
P/E
Price Target
Average
378.18%
Revenue Forecast
Estimate
39.52%
EBIT
Estimate
5.36%
Net Income
Estimate
42.22%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ADC Therapeutics SA
Wall Street analysts predict an average 1-year price target for ADCT of $11.4 , with forecasts ranging from a low of $7 to a high of $20 .
ADCT Lowest Price Target
Wall Street Target
7 USD
192.89%
ADCT Average Price Target
Wall Street Target
11.4 USD
378.18%
ADCT Highest Price Target
Wall Street Target
20 USD
736.82%
REVENUE FORECAST
Revenue Forecast Chart ADCT
EBIT FORECAST
EBIT Forecast Chart ADCT
NET INCOME FORECAST
Net Income Chart ADCT